
Fulgent Genetics Announces Acquisition of Bako Diagnostics, StrataDx
Fulgent Genetics to Acquire Bako Diagnostics Assets and StrataDx in Strategic Expansion of Specialty Pathology and AI-Driven Laboratory Services Fulgent Genetics a technology-enabled diagnostics and therapeutics company, today announced it has entered into a definitive agreement to acquire selected assets…












